Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100050761Phase 4Recruiting
Phase 4 trial of ciprofol and propofol in Not applicable (2 arms), sponsored by Chengdu Jinjiang Maternity and Child Health Hospital. Primary endpoint: Incidence of respiratory related adverse events. Started Jul 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100050761.